Part,  Chapter, Paragraph

 1   II,     5.  1.  1    |  hepatitis B and C virus (HBV and HCV) infection and alcohol drinking.~
 2   II,     5. 12.Acr    |       Union~HBV~Hepatitis B virus~HCV~Hepatitis C virus~ICD~International
 3   II,     5. 12.  1    |  hepatitis B and C virus (HBV and HCV) infection and alcohol drinking:
 4   II,     5. 12.  1    |         important role of HBV and HCV in causing liver cirrhosis,
 5   II,     5. 12.  4    |  hepatitis B and C virus (HBV and HCV) infection (see also Chapter
 6   II,     5. 12.  4    |          association with HBV and HCV (see Chapter 6), cirrhosis
 7   II,     5. 12.  5    |        sse Chapter 6), control of HCV transmission (see Chapter
 8   II,     5. 12.  5    |        against HBV and control of HCV infection will also have
 9   II,     5. 12.  5    |  prevalence and trends of HBV and HCV in various populations;
10   II,     5. 12.  5    |           vaccine, the control of HCV has been later and less
11   II,     5. 12.  5    |           and less effective, but HCV prevalence has remained
12   II,     6.Acr        |        Care Associated Infections~HCV~Hepatitis C Virus~HIB~Haemophilus
13   II,     6.  3.  3    |         by the hepatitis C virus (HCV), for which no vaccine is
14   II,     6.  3.  3    |           available. Up to 90% of HCV infections are asymptomatic.
15   II,     6.  3.  3    |           became rare, as routine HCV tests became more available.~
16   II,     6.  3.  3    | relatively recent introduction of HCV infection into the list
17   II,     6.  3.  3    |     permit a clear picture of the HCV trend in Europe.~ ~
18  III,    10.  2.  1    |    Children~HBV~Hepatitis B Virus~HCV~Hepatitis C Virus~IDU~Injecting
19  III,    10.  2.  1(10)|    implementation and investment. HCV and HBV are monitored through
20  III,    10.  2.  1    |         by the hepatitis C virus (HCV), is much more evenly distributed
21  III,    10.  2.  1    |     million people living with an HCV infection in the EU who
22  III,    10.  2.  1    |      Figure 10.2.1.3.6. Estimated HCV antibody prevalence among
23  III,    10.  2.  1    |       greater extent than that of HCV markers, possibly due to
24   IV,    11.  5.  3    |          of tests (Anti HIV, Anti HCV, Ag-Hbs or Treponema Pallidum).